Forte Biosciences (FBRX) Return on Sales [ROS] (2017 - 2019)
Forte Biosciences (FBRX) reported Return on Sales [ROS] of -17377.78% for Q4 2019, up 194933.33 percentage points from -212311.11% a year earlier but down 9777.78 percentage points from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Return on Sales [ROS] (2017 - 2019) Analysis & Trends
For FY2019, Forte Biosciences posted Return on Sales [ROS] of -11288.89%, down 11034.66 percentage points from FY2018.
- Return on Sales [ROS] has a three-year change of +53384.58 percentage points (FY2016 to FY2019).
- By year, Return on Sales [ROS] came in at -254.23% in FY2018 (+91521.38 pp), -91775.61% in FY2017 (-27102.14 pp) and -64673.47% in FY2016.
- Five-year quarterly Return on Sales [ROS] spans a low of -212311.11% in Q4 2018 and a high of 7.92% in Q3 2018.
- Year over year, Return on Sales [ROS] gained in three of the last seven quarters, with an average year-over-year change of +30581.59 percentage points.
- Per Business Quant data, the three quarters before Q4 2019 came in at -7600.00% (Q3 2019), -6988.89% (Q2 2019) and -187455.56% (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -17,377.78% |
| Sep 30, 2019 | -7,600.00% |
| Jun 30, 2019 | -6,988.89% |
| Mar 31, 2019 | -187,455.56% |
| Dec 31, 2018 | -212,311.11% |
| Sep 30, 2018 | 7.92% |
| Jun 30, 2018 | -170,300.00% |
| Mar 31, 2018 | -142,733.33% |
| Dec 31, 2017 | -106,870.00% |
| Sep 30, 2017 | -97,370.00% |
| Jun 30, 2017 | -86,520.00% |
API Access
Forte Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();